This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Don Riesenberg, MD

JAMA. 1989;262(20):2897.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Diagnosis related groups are 6 years old; Canada's health care system is alternately blessed and cursed; the relative value of cognitive and procedural services sits at the brink. We hardly need to call readers' attention to any JAMA article on economics. However, in this issue of THE JOURNAL Eisenberg¹ offers a primer on clinical economics that deserves brief comment.

Today, there are compelling reasons for physicians to understand more of the "dismal science." Clinicians wonder how adopting a new therapy changes cost vs outcome, investigators seek promising research questions in the face of funding restrictions, and administrators puzzle over which organizational model protects the bottom line while maintaining proper patient care. The solutions to these problems affect not only our patients and us, but payers and society as well. Obviously each party takes a somewhat different view.

Eisenberg,¹ in showing how the tools of economic analysis can help . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?